Project Details
Description
Phase I Randomized Trial of 0.3 mg Linaclotide ?Phase I Double-Blind, Placebo-Controlled Trial of 0.3 mg Linaclotide Delayed-Release (DR1) to Demonstrate Colorectal Bioactivity in Healthy Volunteers
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/18 → 9/30/19 |
Funding
- National Cancer Institute: $206,377.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.